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Results 
A total of 46 collies samples were obtained, primarily from the 
United States. The age of DM affected collies ranged from 3 
months to 11 years (at the time of sampling), while control 
dogs were 7 to 12 years. Case/control analyses were carried 
out using 26 DM-affected and 20 healthy collies (Figure 2a). A 
total of 90 SNPs were significantly associated with DM (Praw 
≤0.0001), 68 of which were located at the centromeric end of 
chromosome 10 (Figure 2b). The most significant result 
obtained was for SNP BICF2P147652, located on 
chromosome 10 at position 5.15Mb (Praw = 3.03 x 10-9). 
Analysis of genotypes in the chromosome 10 region revealed 
a 10.5 Mb haplotype for which all DM-affected collies had at 
least one copy (12 homozygous, 14 heterozygous). The 
haplotype was also present in 60% of healthy collies (2 
homozygous, 10 heterozygous). 
 
 
Materials & Methods 
•  Blood samples from DM-affected and healthy pedigreed collies were 
recruited from the pet population. 
•  All DM-affected collies had a positive or differential diagnosis of 
DM. 
•  All healthy control collies were at least 7 years old, free from any 
dermatologic conditions, unrelated to a DM-affected collie, and 
unrelated to all other study collies within 3 generations. 
•  DNA was isolated from whole blood samples using the DNeasy 
blood and tissue kit (QIAGEN, Valencia, USA) and adjusted to a 
concentration of 100ng/ µL. 
•  Illumina CanineHD Infinium BeadChips were used to profile 173,662 
SNP genotypes per collie. 
•  GenomeStudio was used to analyze the raw data files and generate 
SNP calls. 
•  The PLINK input Report Plug-in v2.1.1 was used to format the data. 
•  By convention, Praw values ≤ 0.0001 were considered significant. 
•  R was used to generate a Manhattan Plot from the –log10 of the Praw 
value for each SNP.  
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Introduction 
Dermatomyositis (DM) is an autoimmune disease of dogs 
characterized by an inflammatory response in the skin and 
muscle tissue, typically around the face, paws, and tail. 
Clinical findings consistent with DM include the development 
of skin lesions such as hair loss, redness, scaling and 
crusting (Figure 1). Dogs afflicted with DM often develop 
disfiguring scarring and secondary skin infections. Signs of 
muscle involvement in severe cases include muscle atrophy, 
megaesophagus, aspiration pneumonia, and difficulty eating 
or walking [1]. Naturally occurring DM in the dog is the only 
animal model available for study of a clinically similar human 
disease termed juvenile dermatomyositis.   
Diagnosis of DM is made by a veterinary histopathologist 
using skin punch biopsies of actively afflicted tissue. Current 
treatment for DM includes the management of symptoms, 
such as severe pain and secondary skin infections. 
Unfortunately, there is no cure for DM and clinical signs may 
reoccur. Onset of DM ranges from two months to several 
years of age. A dog may have produced multiple litters before 
the onset of clinical signs, making it difficult for breeders to 
control disease transmission.  
The two breeds with the highest prevalence of DM are collies 
and Shetland sheepdogs [1 - 3]. The inheritance of DM is 
suggested to be autosomal dominant [2]. Anecdotal reports 
suggest that triggers for developing DM may include 
vaccination, abrasion, estrus, or abandonment. In this study, 
we sought to use a genome-wide association study to 
identify the genetic factor(s) underlying DM in the collie 
breed.  
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Figure 1. Collie and Shetland  sheepdogs affected with 
dermatomyositis. Skin lesions are shown on the face and feet. 
Discussion 
In this study we utilized genome-wide SNP profiles to identify 
a genomic region associated with DM. The majority of 
associated SNPs, and those with the most significant p-
values, were clustered on chromosome 10. A large haplotype 
spanning this region is present in all DM-affected collies.  
These data support an autosomal dominant mode of 
inheritance, as all affected dogs carried one or two copies of 
the associated haplotype. Because the haplotype was also 
present among controls, the allele shows reduced 
penetrance, perhaps due to an environmental trigger. While 
we were unable to grade the severity of the clinical signs in 
all participants, it is interesting that puppies younger at age 
of onset were more often homozygous. This finding suggests 
that while one copy is sufficient for disease onset, two copies 
may cause a younger age of onset and/or a more severe 
phenotype. 
The associated haplotype harbors ~100 genes, including 
several with an immune related function. To reduce the 
number of candidate genes, future studies will focus on DM 
in Shetland sheepdogs. These herding breeds share a recent 
common ancestor and likely share a founding mutation. An 
across-breed approach will allow us to use differences in 
homogeneity that exist between the breeds to narrow the 
haplotype. We have identified a locus on chromosome 10 that 
likely harbors a genetic factor underlying DM. 
 
Figure 2. Genome-wide association for DM using 26 affected and 20 healthy control collies. (a) Raw P values (-log10 Praw) for each SNP are 
plotted by chromosome and reveal a strong association on chromosome 10 (b) The raw P values are plotted against position on 
chromosome 10 and show that the significant SNPs are clustered near the centromeric end. 
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